BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 29
• 30

• Drug Development

  Roche’s Perjeta Regimen Helped People With HER2-Positive Early Breast Cancer Live Longer Without Their Disease Returning Or Getting Worse Compared To Herceptin And Chemotherapy

  June 1, 2015

   · 

  8 min read
• Drug Development

  Pharming Group Announces Interim Results From The Ongoing Phase II Pediatric Clinical Trial Of Ruconest

  June 1, 2015

   · 

  7 min read
• Business

  Merus Appoints Mark Iwicki As President Of The Supervisory Board

  June 1, 2015

   · 

  2 min read
• Business

  Motif Partners With Leading Global CRO For Phase III Clinical Trials With Iclaprim

  June 1, 2015

   · 

  2 min read
• Business

  Uli Hacksell, Ph.D., Joins Glionova As Chairman Of The Board

  June 1, 2015

   · 

  2 min read
• Business

  Merck & Co. And Dynavax Technologies Corporation Announce New Collaboration Investigating The Combination Of Immuno-Oncology Therapies

  June 1, 2015

   · 

  13 min read
• Deals

  Celladon Seeks Sale or Partnership and Promotes Paul Cleveland to CEO

  June 1, 2015

   · 

  3 min read
• Drug Development

  ASCO15: Immunomedics, Inc. Reports Complete Responses In Patients With Metastatic Triple-Negative Breast Cancer After Sacituzumab Govitecan Treatment

  June 1, 2015

   · 

  8 min read
• Policy

  Elusys Therapeutics, Inc. Release: U.S. FDA Accepts Biologics License Application For Anthim (Obiltoxaximab)

  June 1, 2015

   · 

  4 min read
• Pharm Country

  New Study Shows Cefaly Returns Normal Metabolic Activity To Brain Areas In Migraine Patients

  June 1, 2015

   · 

  2 min read